CONMED Statistics
Total Valuation
CONMED has a market cap or net worth of $1.15 billion. The enterprise value is $1.96 billion.
Important Dates
The last earnings date was Wednesday, April 29, 2026, after market close.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Sep 15, 2025 |
Share Statistics
CONMED has 30.11 million shares outstanding. The number of shares has decreased by -0.33% in one year.
| Current Share Class | 30.11M |
| Shares Outstanding | 30.11M |
| Shares Change (YoY) | -0.33% |
| Shares Change (QoQ) | -1.32% |
| Owned by Insiders (%) | 0.87% |
| Owned by Institutions (%) | 113.66% |
| Float | 29.83M |
Valuation Ratios
The trailing PE ratio is 21.56 and the forward PE ratio is 8.44. CONMED's PEG ratio is 1.62.
| PE Ratio | 21.56 |
| Forward PE | 8.44 |
| PS Ratio | 0.83 |
| Forward PS | 0.81 |
| PB Ratio | 1.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.18 |
| P/OCF Ratio | 7.97 |
| PEG Ratio | 1.62 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.03, with an EV/FCF ratio of 15.86.
| EV / Earnings | 35.77 |
| EV / Sales | 1.43 |
| EV / EBITDA | 10.03 |
| EV / EBIT | 16.08 |
| EV / FCF | 15.86 |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.85.
| Current Ratio | 2.29 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 4.17 |
| Debt / FCF | 6.96 |
| Interest Coverage | 4.09 |
Financial Efficiency
Return on equity (ROE) is 5.50% and return on invested capital (ROIC) is 4.39%.
| Return on Equity (ROE) | 5.50% |
| Return on Assets (ROA) | 3.31% |
| Return on Invested Capital (ROIC) | 4.39% |
| Return on Capital Employed (ROCE) | 6.03% |
| Weighted Average Cost of Capital (WACC) | 6.36% |
| Revenue Per Employee | $351,414 |
| Profits Per Employee | $14,063 |
| Employee Count | 3,900 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, CONMED has paid $26.95 million in taxes.
| Income Tax | 26.95M |
| Effective Tax Rate | 32.95% |
Stock Price Statistics
| Beta (5Y) | 0.94 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 38.13 |
| 200-Day Moving Average | 43.98 |
| Relative Strength Index (RSI) | 49.61 |
| Average Volume (20 Days) | 438,347 |
Short Selling Information
The latest short interest is 846,967, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 846,967 |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.81% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 5.60 |
Income Statement
In the last 12 months, CONMED had revenue of $1.37 billion and earned $54.85 million in profits. Earnings per share was $1.77.
| Revenue | 1.37B |
| Gross Profit | 740.97M |
| Operating Income | 121.99M |
| Pretax Income | 81.80M |
| Net Income | 54.85M |
| EBITDA | 195.66M |
| EBIT | 121.99M |
| Earnings Per Share (EPS) | $1.77 |
Full Income StatementBalance Sheet
The company has $35.03 million in cash and $860.87 million in debt, with a net cash position of -$825.84 million or -$27.43 per share.
| Cash & Cash Equivalents | 35.03M |
| Total Debt | 860.87M |
| Net Cash | -825.84M |
| Net Cash Per Share | -$27.43 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 33.76 |
| Working Capital | 377.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $142.63 million and capital expenditures -$18.92 million, giving a free cash flow of $123.71 million.
| Operating Cash Flow | 142.63M |
| Capital Expenditures | -18.92M |
| Depreciation & Amortization | 73.67M |
| Net Borrowing | -35.00M |
| Free Cash Flow | 123.71M |
| FCF Per Share | $4.11 |
Full Cash Flow StatementMargins
Gross margin is 54.07%, with operating and profit margins of 8.90% and 4.00%.
| Gross Margin | 54.07% |
| Operating Margin | 8.90% |
| Pretax Margin | 5.97% |
| Profit Margin | 4.00% |
| EBITDA Margin | 14.28% |
| EBIT Margin | 8.90% |
| FCF Margin | 9.03% |
Dividends & Yields
This stock pays an annual dividend of $0.40, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | $0.40 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.60% |
| Buyback Yield | 0.33% |
| Shareholder Yield | 1.40% |
| Earnings Yield | 4.83% |
| FCF Yield | 10.89% |
Dividend DetailsAnalyst Forecast
The average price target for CONMED is $42.40, which is 11.11% higher than the current price. The consensus rating is "Hold".
| Price Target | $42.40 |
| Price Target Difference | 11.11% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on September 10, 2001. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Sep 10, 2001 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
CONMED has an Altman Z-Score of 2.01 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 7 |
